AKUMS2024-10-012024-12-31 AKUMS2024-10-012024-12-31 AKUMS2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member AKUMS2024-10-012024-12-31in-bse-fin:OneOperatingExpenses02Member AKUMS2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member AKUMS2024-10-012024-12-31in-bse-fin:FourOperatingExpenses02Member AKUMS2024-12-31 AKUMS2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue01Member AKUMS2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue02Member AKUMS2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue03Member AKUMS2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue01Member AKUMS2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue02Member AKUMS2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue03Member AKUMS2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults01Member AKUMS2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults02Member AKUMS2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults03Member AKUMS2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults01Member AKUMS2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults02Member AKUMS2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults03Member AKUMS2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets01Member AKUMS2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets02Member AKUMS2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets03Member AKUMS2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member AKUMS2024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member AKUMS2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member AKUMS2024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member AKUMS2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities03Member AKUMS2024-12-31in-bse-fin:OneReportableSegmentLiabilities03Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 544222 AKUMS NOTLISTED Akums Drugs and Pharmaceuticals Limited Equity 2024-04-01 2025-03-31 2025-02-06 2025-02-01 INR Millions Third quarter 15:30:00 16:15:00 2025-02-06 2025-02-06 Not applicable Multi segment 2024-10-01 2024-12-31 Unaudited Consolidated 10104110000.00 145610000.00 10249720000.00 5645980000.00 302720000.00 75230000.00 1755980000.00 51340000.00 445200000.00 1110550000.00 9387000000.00 862720000.00 47810000.00 910530000.00 187450000.00 59960000.00 247410000.00 0.00 663120000.00 0.00 0.00 0.00 0.00 663120000.00 1690000.00 664810000.00 651820000.00 11300000.00 653640000.00 11170000.00 306210000.00 2 4.26 4.26 0.00 0.00 4.26 4.26 Multi segment 2024-04-01 2024-12-31 Unaudited Consolidated 30626110000.00 345770000.00 30971880000.00 16297630000.00 1619830000.00 26020000.00 5319240000.00 300580000.00 1134490000.00 3657720000.00 28355510000.00 2616370000.00 84800000.00 2701170000.00 615560000.00 143900000.00 759460000.00 0.00 1941710000.00 0.00 0.00 0.00 0.00 1941710000.00 -790000.00 1940920000.00 1905590000.00 36120000.00 1904770000.00 36150000.00 306210000.00 2 12.84 12.84 0.00 0.00 12.84 12.84 Fair value changes to financial instruments 0.00 Other Expenses 1110550000.00 Fair value changes to financial instruments -38670000.00 Other Expenses 3696390000.00 API 477880000.00 Branded and generic formulations 1829320000.00 CDMO 8430410000.00 API 2105110000.00 Branded and generic formulations 5253820000.00 CDMO 25394850000.00 10737610000.00 32753780000.00 819990000.00 819990000.00 9917620000.00 31933790000.00 API -210480000.00 Branded and generic formulations 173060000.00 CDMO 879660000.00 API -617670000.00 Branded and generic formulations 500360000.00 CDMO 2762410000.00 842240000.00 2645100000.00 36250000.00 252190000.00 -56730000.00 -223460000.00 862720000.00 2616370000.00 API 4372270000.00 Branded and generic formulations 2494180000.00 CDMO 27918560000.00 34785010000.00 4697690000.00 39482700000.00 API 351870000.00 Branded and generic formulations 2272880000.00 CDMO 6824460000.00 9449210000.00 898890000.00 10348100000.00 2480000.00 -1070000.00 790000.00 -280000.00 0.00 0.00